Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ZANZUEL & KLINIKK NOVA AS
AS
Active
Org 976060407
Skippergata 38, 4611 Kristiansand S
Wholesale of perfume and cosmetics · NACE 4645
Est. 1996
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,1M
-33% vs 2023
EBITDA margin
-6.1%
-228% vs 2023
Equity ratio
-83.9%
Financial strength
Net profit 2024
NOK -611K
-2581% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2,1M
-33%
EBITDA
NOK -131K
-228%
Net profit
NOK -611K
-2581%
Total assets
NOK 994K
-37%
Equity
NOK -834K
-34%
Employees
3
—
Company information
Legal name
ZANZUEL & KLINIKK NOVA AS
Org number
976060407
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
31. januar 1996
Share capital
NOK 200 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Contact
Address
Skippergata 38, 4611 Kristiansand S
Email
post@klinikknova.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of perfume and cosmetics
Companies in Kristiansand
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
5M
4M
2020
4M
2021
4M
2022
3M
2023
2M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 592
4 159
4 141
3 195
2 133
Staff expenses
−316
−858
−902
−687
−367
EBITDA
52
−27
16
102
−131
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
52
−27
16
102
−131
Net financials
−53
−49
−54
−71
−79
Profit before tax
−1
−76
−38
32
−210
Tax
1
−16
−8
7
401
Net profit
−2
−60
−30
25
−611
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 884
1 848
1 784
1 581
994
Equity
−1 157
−1 217
−847
−622
−834
Long-term debt
2 331
2 244
1 755
1 492
1 066
Short-term debt
710
821
875
711
762
Total debt
3 040
3 065
2 631
2 203
1 827
Financial ratios
5-year trend
EBITDA margin
-6.1%
This company
15.8%
Market median
-139% vs market
2020
2024
Equity ratio
-83.9%
This company
38.2%
Market median
-320% vs market
2020
2024
Return on equity
-61146200.0%
This company
18.4%
Market median
-332316404% vs market
2020
2024
Net profit margin
-28.7%
This company
8.1%
Market median
-454% vs market
2020
2024
Asset turnover
2.15×
This company
1.12×
Market median
+92% vs market
2020
2024
Debt / equity
2.19×
This company
0.62×
Market median
-253% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AE
Alexandra Eleni Cascampas
Board of Directors
2022
TR
Tone Rødde Cascampas
Chairman
2022
Former (1)
TA
Terje Antonis Spyridon Cascampas
Chairman
2014 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Solvang Gård Invest As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Solvang Gård Invest As
ZANZUEL & KLINIKK NOVA AS
(this company)
Board network connections
Board members of ZANZUEL & KLINIKK NOVA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Alexandra Eleni Cascampas
Board of Directors
0 companies
Tone Rødde Cascampas
Chairman
0 companies
Terje Antonis Spyridon Cascampas
Chairman
0 companies